Roman Wieczorek

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease models.

Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease models.

Journal: Alternatives to laboratory animals : ATLA

Published: August 14, 2026

Next generation nicotine product aerosol extracts exhibit reduced toxicological effects compared to cigarette smoke extracts in the ToxTracker Antioxidant and ToxProfiler MAX assays.

Next generation nicotine product aerosol extracts exhibit reduced toxicological effects compared to cigarette smoke extracts in the ToxTracker Antioxidant and ToxProfiler MAX assays.

Journal: Mutagenesis

Published: April 16, 2026

Assessment of heated herbal products' tobacco harm reduction potential: pre-clinical and clinical studies.

Assessment of heated herbal products' tobacco harm reduction potential: pre-clinical and clinical studies.

Journal: Frontiers in toxicology

Published: March 12, 2025

Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products.

Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products.

Journal: Frontiers in toxicology

Published: March 04, 2024

Use of quantitative in vitro to in vivo extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols.

Use of quantitative in vitro to in vivo extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols.

Journal: Frontiers in toxicology

Published: January 19, 2024

Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters.

Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters.

Journal: Alternatives to laboratory animals : ATLA

Published: February 23, 2023

Characterisation of a smoke/ aerosol exposure in vitro system (SAEIVS) for delivery of complex mixtures directly to cells at the air-liquid interface.

Characterisation of a smoke/ aerosol exposure in vitro system (SAEIVS) for delivery of complex mixtures directly to cells at the air-liquid interface.

Journal: Journal of applied toxicology : JAT

Published: October 24, 2022

Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke.

Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke.

Journal: Frontiers in toxicology

Published: October 21, 2022

Ciliary Beat Frequency: Proceedings and Recommendations from a Multi-laboratory Ring Trial Using 3-D Reconstituted Human Airway Epithelium to Model Mucociliary Clearance.

Ciliary Beat Frequency: Proceedings and Recommendations from a Multi-laboratory Ring Trial Using 3-D Reconstituted Human Airway Epithelium to Model Mucociliary Clearance.

Journal: Alternatives to laboratory animals : ATLA

Published: August 08, 2022

Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry.

Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry.

Journal: Drug testing and analysis

Published: March 18, 2022

Multiple endpoint in vitro toxicity assessment of a prototype heated tobacco product indicates substantially reduced effects compared to those of combustible cigarette.

Multiple endpoint in vitro toxicity assessment of a prototype heated tobacco product indicates substantially reduced effects compared to those of combustible cigarette.

Journal: Toxicology in vitro : an international journal published in association with BIBRA

Published: September 28, 2021

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.

Journal: Frontiers in toxicology

Published: July 26, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026